Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,662,629
-
Share change
-
-804,436
-
Total reported value
-
$61,867,597
-
Put/Call ratio
-
20%
-
Price per share
-
$1.56
-
Number of holders
-
94
-
Value change
-
-$681,730
-
Number of buys
-
36
-
Number of sells
-
48
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q3 2016
As of 30 Sep 2016,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,662,629 shares.
The largest 10 holders included
VANGUARD GROUP INC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Fund Advisors, DEERFIELD MANAGEMENT CO, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., PINNACLE ASSOCIATES LTD, and FMR LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.